Unleashing Innovation: The Case for Permissionless R&D in Pharma
A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior…![](https://www.drugpatentwatch.com/blog/wp-content/plugins/matomo/app/matomo.php?idsite=1&rec=1&url=https%3A%2F%2Fwww.drugpatentwatch.com%2Fblog%2Funleashing-innovation-the-case-for-permissionless-rd-in-pharma%2F&action_name=Unleashing%20Innovation%3A%20The%20Case%20for%20Permissionless%20R%26amp%3BD%20in%20Pharma&urlref=https%3A%2F%2Fwww.drugpatentwatch.com%2Fblog%2Ffeed%2F)